Qingdao NovelBeam Technology Co.,Ltd. Share Price

Equities

688677

CNE100005410

Advanced Medical Equipment & Technology

End-of-day quote Shanghai S.E. 03:30:00 30/04/2024 am IST 5-day change 1st Jan Change
44.78 CNY +0.36% Intraday chart for Qingdao NovelBeam Technology Co.,Ltd. +3.20% -15.87%

Financials

Sales 2023 471M 64.99M 5.42B Sales 2024 * 607M 83.9M 7B Capitalization 5.45B 752M 62.76B
Net income 2023 146M 20.16M 1.68B Net income 2024 * 206M 28.45M 2.37B EV / Sales 2023 13.8 x
Net cash position 2023 * - 0 0 Net cash position 2024 * - 0 0 EV / Sales 2024 * 8.97 x
P/E ratio 2023
44.4 x
P/E ratio 2024 *
26.4 x
Employees 854
Yield 2023
1.03%
Yield 2024 *
1.34%
Free-Float 56.21%
More Fundamentals * Assessed data
Dynamic Chart
Qingdao NovelBeam Technology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Tranche Update on Qingdao NovelBeam Technology Co.,Ltd.'s Equity Buyback Plan announced on June 16, 2023. CI
Qingdao NovelBeam Technology Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Tranche Update on Qingdao NovelBeam Technology Co.,Ltd.'s Equity Buyback Plan announced on June 16, 2023. CI
Qingdao NovelBeam Technology Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Tranche Update on Qingdao NovelBeam Technology Co.,Ltd.'s Equity Buyback Plan announced on June 16, 2023. CI
Qingdao NovelBeam Technology Co.,Ltd.(XSSC:688677) added to S&P Global BMI Index CI
Qingdao NovelBeam Technology Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Tranche Update on Qingdao NovelBeam Technology Co.,Ltd.'s Equity Buyback Plan announced on June 16, 2023. CI
Qingdao NovelBeam Technology Co.,Ltd. announces an Equity Buyback for CNY 60 million worth of its shares. CI
Qingdao NovelBeam Technology Co.,Ltd. authorizes a Buyback Plan. CI
Qingdao NovelBeam Technology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Tranche Update on Qingdao NovelBeam Technology Co.,Ltd.'s Equity Buyback Plan announced on April 1, 2022. CI
Qingdao NovelBeam Technology Co.,Ltd.'s Equity Buyback announced on April 1, 2022, has closed with 336,548 shares, representing 0.39% for CNY 30.11 million. CI
Qingdao NovelBeam Technology Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
More news
1 day+0.36%
1 week+3.20%
1 month-9.68%
3 months-4.72%
6 months-21.88%
Current year-15.87%
More quotes
1 week
43.49
Extreme 43.49
46.49
1 month
39.11
Extreme 39.11
49.46
Current year
39.11
Extreme 39.11
58.00
1 year
39.11
Extreme 39.11
75.49
3 years
39.11
Extreme 39.11
102.06
5 years
39.11
Extreme 39.11
102.06
10 years
39.11
Extreme 39.11
102.06
More quotes
Managers TitleAgeSince
Chief Executive Officer 50 -
Director of Finance/CFO 56 01/04/01
Chairman 42 01/07/01
Members of the board TitleAgeSince
Chairman 59 -
Director/Board Member 60 28/19/28
Director/Board Member 55 26/15/26
More insiders
Date Price Change Volume
30/24/30 44.78 +0.36% 1,645,111
29/24/29 44.62 +2.83% 2,155,352
26/24/26 43.39 +2.82% 1,790,813
25/24/25 42.2 +3.00% 2,766,950

End-of-day quote Shanghai S.E., April 30, 2024

More quotes
Qingdao NovelBeam Technology Co Ltd is a China-based company principally engaged in the research and development, production and sales of medical endoscopic equipment and optical products. Its main products of medical endoscope equipment include fluorescent endoscopes, fluorescent camera adapters/adaptive lenses, fluorescent light source modules and white light source modules. Its medical endoscopic equipment products are mainly used in abdominal endoscopic surgery such as liver and gallbladder and gastrointestinal surgery. Its optical products mainly include medical optical products, industrial and laser optical products, and biometric products. Among them, the biometric products include fingerprint devices, palmprint devices and related accessories. In addition, the Company also provides technical services and house leasing services. The Company distributes its products both in the domestic market and to overseas markets.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
44.78 CNY
Average target price
59 CNY
Spread / Average Target
+31.76%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 688677 Stock